Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Biomedicines
|
May 25, 2017
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
Valentina Sala, Simona Gallo, Stefano Gatti, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 12, 2012
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies
Valentina Sala, Simona Gallo, Christian Leo, et al.
International Journal of Molecular Sciences
|
July 30, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
Simona Gallo, Martina Spilinga, Elena Casanova, et al.
Biomed Research International
|
June 15, 2016
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
Valentina Sala, Stefano Gatti, Simona Gallo, et al.
Frontiers in Cell and Developmental Biology
|
June 28, 2021
HGF and MET: From Brain Development to Neurological Disorders
Claudia Desole, Simona Gallo, Annapia Vitacolonna, et al.
Cancers
|
April 5, 2020
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
Chiara Modica, Simona Gallo, Cristina Chiriaco, et al.
Transgenic Research
|
December 11, 2012
Gene expression profiling of HGF/Met activation in neonatal mouse heart
Stefano Gatti, Christian Leo, Simona Gallo, et al.
British Journal of Plastic Surgery
|
November 17, 2004
Early reconstruction of the abdominal wall in giant omphalocele
Mario Zama, Simona Gallo, Luigino Santecchia, et al.
British Journal of Pharmacology
|
March 6, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro
Simona Gallo, Martina Spilinga, Raffaella Albano, et al.
Journal of Molecular and Cellular Cardiology
|
March 1, 2016
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
Valentina Sala, Simona Gallo, Stefano Gatti, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Biomedicines
|
May 25, 2017
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
Valentina Sala, Simona Gallo, Stefano Gatti, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 12, 2012
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies
Valentina Sala, Simona Gallo, Christian Leo, et al.
International Journal of Molecular Sciences
|
July 30, 2020
The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
Simona Gallo, Martina Spilinga, Elena Casanova, et al.
Biomed Research International
|
June 15, 2016
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
Valentina Sala, Stefano Gatti, Simona Gallo, et al.
Frontiers in Cell and Developmental Biology
|
June 28, 2021
HGF and MET: From Brain Development to Neurological Disorders
Claudia Desole, Simona Gallo, Annapia Vitacolonna, et al.
Cancers
|
April 5, 2020
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
Chiara Modica, Simona Gallo, Cristina Chiriaco, et al.
Transgenic Research
|
December 11, 2012
Gene expression profiling of HGF/Met activation in neonatal mouse heart
Stefano Gatti, Christian Leo, Simona Gallo, et al.
British Journal of Plastic Surgery
|
November 17, 2004
Early reconstruction of the abdominal wall in giant omphalocele
Mario Zama, Simona Gallo, Luigino Santecchia, et al.
British Journal of Pharmacology
|
March 6, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro
Simona Gallo, Martina Spilinga, Raffaella Albano, et al.
Journal of Molecular and Cellular Cardiology
|
March 1, 2016
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
Valentina Sala, Simona Gallo, Stefano Gatti, et al.
Page
of 3